Gary Moon is taking senior meetings at HLTH in Las Vegas. Request a meeting →

HEALTHCARE IT & HEALTHTECH

Clinical efficiency and regulatory complexity demand specialized advisory.

Healthcare technology is shifting from point-solution proliferation to deep platform consolidation. Whether you provide clinical workflow tools, payer analytics, or patient engagement software, we position your business to capture peak valuation from strategic acquirers and healthcare-dedicated private equity.

0+

Firmwide completed deals

$0B+

Aggregate transaction value

0%

Managing partner-led execution

YOUR BANKER

Meet the senior banker who will run your process.

Gary co-founded Nfluence and leads our Healthcare IT advisory practice. A former technology founder and CEO himself, Gary brings over two decades of high-stakes technology M&A experience to every founder conversation.

Gary Moon executive discussion

Advising healthcare IT and enterprise SaaS founders on transformative M&A and capital formation. Direct senior execution without junior hand-offs.

Gary Moon

Gary Moon

Managing Partner & Co-Founder

WHAT WE DO

Sell the company, or fund the next stage. Same preparation either way.

We advise healthcare technology founders on achieving landmark liquidity events, whether through a strategic acquisition, growth equity round, or private equity recapitalization.

M&A advisory

Maximizing transaction value and protecting key deal terms in high-stakes healthcare processes.

  • Sell-side M&A engineered across strategic healthcare conglomerates and private equity
  • Strategic acquisitions and corporate carve-outs
  • Cross-border transaction structuring and regulatory approvals
  • Board advisory on unsolicited inbound acquisition proposals
  • Detailed valuation benchmarking across public comps and precedent HealthTech deals

Capital formation

Securing growth capital from top-tier institutional investors with deep healthcare domain expertise.

  • Growth equity rounds from dedicated healthcare IT and enterprise SaaS sponsors
  • Structured debt, ARR credit facilities, and non-dilutive financing
  • Founder recapitalizations and partial liquidity events
  • Strategic investments from payer, provider, and pharma corporate venture funds
  • Preparation for future M&A readiness and KPI audit

YOUR OPTIONS

One buyer is a negotiation. Several buyers is a market.

Every banker says they run a competitive process. Here is what actually changes depending on which route you take.

Run a full process

RECOMMENDED
Buyers at the table

Enough that no single party sets the terms

What you learn about the market

What the market will actually pay, priced by competition

Time required

Four to seven months

Disruption to the business

Highest, and planned for

Your negotiating position

Real alternatives, including walking away

Confidentiality

Managed deliberately, under NDA and staged disclosure

Timeframes are typical ranges for middle-market technology transactions and vary by company, sector, and market conditions.

M&ATravel & Hospitality Tech2026
Prismm

Acquired by Cvent (Blackstone)

Exclusive financial advisor to the seller

M&AEducation Technology2026
Wayfinder

Has been acquired by LEMNIS

Financial advisor on its sale to LEMNIS

Capital RaiseCrypto & FinTech2026
CoinFlip

Strategic recapitalization

Lead placement agent

M&AHospitality Software2025
vOffice

Acquired by Visit Group, a portfolio company of PSG

Financial advisor to the seller

M&AData & Analytics2025
NGL Labs

Has been acquired by Mode Mobile

Exclusive financial advisor to the seller

M&AHospitality Software2025
Easy Booking

Has been acquired by Zucchetti

Exclusive financial advisor to the seller

Capital RaiseHospitality & Events Tech2025
Prismm

Growth debt financing from Trinity Capital and Level Equity Financing

Lead placement agent

M&AFintech & Digital Assets2024
3iQ

Has been acquired by Monex Financial Group / Coincheck

Exclusive financial advisor to the seller

M&AHealthcare IT & Patient Access2024
SpinSci

Acquired by Aldrich Capital Partners

Exclusive financial advisor to the company

Capital RaiseHealthcare IT & RCM2024
PracticeSuite

Advised PracticeSuite on acquisition of MicroMD

Exclusive financial advisor to the buyer

Capital RaiseCreator Economy & MarTech2024
MagicLinks

Received financing from Heritage Bank of Commerce

Capital raise lead

M&APractice Management & EHR2024
MicroMD

Carve-out from Henry Schein acquired by PracticeSuite

Exclusive financial advisor to the buyer

M&AAccessibility Tech & GRC2024
UserWay

Acquired by Level Access, a portfolio company of KKR & JMI Equity

Financial advisor to the seller

M&ADental SaaS & HealthTech2024
Kleer

Has been acquired by Charlesbank Capital Partners

Exclusive financial advisor to the seller

M&APropTech & WealthTech2024
Cadre

Has been acquired by Yieldstreet

Exclusive financial advisor to the seller

Capital RaiseFintech & Accounting2023
Clearwater Analytics

Follow-on public offering

Financial advisor on follow-on equity offering

M&AInsurTech & Pension Software2023
WinTech

Has been acquired by Constellation Software

Exclusive financial advisor to the seller

M&ADigital Media & Music2023
LyricFind

Advised on strategic acquisition of Rotor Video

Exclusive financial advisor to the buyer

* Select transactions shown. Includes current Nfluence bankers' experience at prior firms. Full track record available upon request.

Deal TypeCategoryYear

Transaction Statement

THE MARKET READ

Providers and payers are eliminating fragmented point solutions.

$65.4B

Healthcare IT and digital health transaction value across strategic M&A and buyouts in 2026.

68%

Of enterprise health systems consolidating vendor contracts into unified software suites.

4.8x

Median ARR multiple for HealthTech platforms demonstrating verifiable ROI in clinical labor reduction.

Health systems and payers are facing persistent margin pressures, driving urgent demand for software that automates clinical documentation, accelerates revenue cycle turnaround, and enables value-based care contracts.

Buyers are aggressively prioritizing platforms with deeply integrated EHR workflows, robust regulatory compliance, and provable economic return over speculative consumer wellness apps.

For HealthTech companies scaling past $10M in ARR, positioning requires demonstrating low customer churn among enterprise health networks, strong gross margins, and clear defensibility against legacy incumbents.

A competitive M&A process creates tension between strategic healthcare conglomerates seeking modern cloud capabilities and well-capitalized private equity platforms executing buy-and-build strategies.

Rock Health, PitchBook Healthcare Report, and Nfluence Partners proprietary healthcare transaction database.

Las Vegas conference skyline

WHERE WE'LL BE

Meet us at HLTH in Las Vegas.

Gary Moon will be meeting with healthcare technology founders, board members, and strategic investors during HLTH.

OCT19-222026
VENUE

The Venetian Expo. Las Vegas, Nevada

ATTENDING

Gary Moon, Managing Partner & Co-Founder

What the meeting is

A private, confidential discussion focused on your strategic roadmap, current M&A market conditions for health tech, and what top-tier buyers are looking for in terms of EHR integration, clinical validation, and contract length.

Discuss whether your current scale positions you best for a strategic sale, PE growth recapitalization, or structured debt facility.

Request a meeting

Meeting availability during HLTH is limited. We recommend scheduling several weeks prior to the event.

Request a meeting with Gary

Not attending HLTH? Gary is available for meetings in Silicon Valley, New York, or via Zoom. Book a confidential discussion.

FAQ

Questions HealthTech founders
ask first.

How do buyers evaluate regulatory compliance and HIPAA/HITRUST certification?

Enterprise healthcare buyers and private equity firms conduct rigorous technical and compliance audits. Having established SOC 2 Type II, HIPAA safeguards, and HITRUST certifications materially reduces diligence friction and defends valuation multiples.

Our sales cycle to enterprise health systems is long. How does this affect valuation?

While long sales cycles are typical in healthcare IT, buyers look for high net retention (>110%), multi-year contracts, and low gross churn to validate that enterprise customers rarely leave once onboarded.

Should we sell to a healthcare strategic or a private equity platform?

We structure processes to include both. Strategics often offer compelling synergy value and commercial reach, while PE platforms provide substantial rollover equity upside and operational autonomy.

When should we begin preparing for a transaction?

Preparation should ideally start 12 to 18 months prior to going to market. This provides sufficient time to refine customer cohorts, formalize IP ownership, and optimize financial reporting.

How is patient health information (PHI) protected during M&A diligence?

Strict protocols are enforced: no raw PHI is ever uploaded to virtual data rooms. Diligence focuses on anonymized cohort data, audit logs, and security architecture validation under strict mutual NDAs.